AbbVie Sues To Block Dr. Reddy's Generic Leukemia Drug
AbbVie Inc. has accused generic drugmaker Dr. Reddy's Laboratories of prematurely pressing for a generic version of a prize-winning leukemia medication, in a suit filed in New Jersey federal court....To view the full article, register now.
Already a subscriber? Click here to view full article